Search

everythinglearnresearchcommunity

for

Search:↓

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Frontal fibrosing alopecia is a type of hair loss that usually happens after menopause.

Ovarian hyperthecosis can cause polycythemia, and surgery can normalize symptoms.

Erlotinib can cause unusual hair growth, like long eyelashes and facial hair.

A woman's high testosterone and related symptoms were caused by overactive cells in her ovaries.

Combination of 0.25% finasteride and 3% minoxidil works better than just 3% minoxidil for increasing hair thickness in women.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.

Ovarian hyperthecosis can cause symptoms even with normal testosterone levels, and surgery can improve these symptoms.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Leydig cell tumors can cause high testosterone in women and are treated by removing the ovaries.

Quality of life, overall survival, and progression-free survival should be equally prioritized in advanced breast cancer treatment decisions.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

A woman's hair loss was linked to a rare hormone-secreting ovarian tumor, treated with surgery and hair loss medication.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Chemotherapy can harm kidneys in breast cancer patients.

Maintaining sexual health after menopause is possible with patient approaches, hormone supplements, and therapy, despite needing more research.

A woman's pelvic pain and bleeding led to finding and successfully treating a rare benign tumor in her reproductive system.

Estetrol may help prevent hair loss and support hair growth in women.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

Non-drug treatments like saw palmetto, horsetail, pumpkin seed oil, curcumin, and addressing nutritional deficiencies may help female hair loss.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.